Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxynitrite-mediated protein modification refers to the chemical alteration of proteins by peroxynitrite (\(\mathrm{ONOO}^-\( ), a highly reactive nitrogen species formed from the reaction between nitric oxide and superoxide. The most prominent modifications include **nitration and dimerization of tyrosine residues**, **oxidation of cysteine thiol groups**, and **oxidation of methionine sulfur groups**. These changes can modulate or inhibit enzymatic activity, disrupt metal-sulfur clusters in proteins, interfere with cellular redox signaling, promote cell damage or death, and alter immune responses. Such modifications are implicated in various pathophysiological conditions including cardiovascular diseases, neurodegeneration, inflammation, and vascular disorders. While these processes are biologically significant—affecting functions such as signal transduction and cell survival—they do not represent classical therapeutic targets like receptors or enzymes but rather post-translational events contributing to disease pathology.[1][2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxynitrite-mediated protein modification.